Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
SBRT Alone or Followed by Niraparib for Oligometastases or Oligoprogression in Ovarian Cancer Following PARPi TherapyAdnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorderRecruitingPhase 22026-07-13NCT05990192

2 results · Page 1 of 1

Swipe the table sideways for more columns.

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Leicester Royal InfirmaryLeicesterUnited Kingdom1
St James's University HospitalLeedsUnited Kingdom1
The Christie NHS Foundation TrustManchesterUnited Kingdom2
The Royal Marsden NHS Foundation TrustLondonUnited Kingdom41
The Royal Marsden NHS Foundation TrustSuttonUnited Kingdom21
University College London HospitalsLondonUnited Kingdom1
Western General HospitalEdinburghUnited Kingdom9